Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
4 clinical trials · Sponsor
◉ Watch Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| VB19055 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Healthy Chinese Population (NCT07254481) | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | 2025-10-05 |
| Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors (NCT06819215) | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | 2024-10-30 |
| Study of TFX06 in Women With Advanced Breast Cancer. (NCT05927779) | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | 2023-04-17 |
| A Study of TFX05-01 in Patients With Advanced Solid Tumors (NCT05434299) | Zhejiang Yangli Pharmaceutical Technology Co., Ltd. | 2022-06-05 |
Track Zhejiang Yangli Pharmaceutical Technology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.